As of August 28, 2026, Jyong Biotech Ltd. (MENS) has a DilutionWatch DilutionScore of 56/100, rated HIGH dilution risk. Jyong Biotech Ltd. has a market capitalization of $167.26M, 76.03M shares outstanding, 17 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
⛅
Watch
Minor dilution signals detected
model est. 22%
💰 Capital Raise
model 35%
• Low cash runway: 5 months remaining
🔄 Reverse Split
model est. 15%
• Only 5 months cash — financial pressure
Market Data
Market Cap$167.26M
Shares Outstanding76.03M
Float26.94M
Cash$1.18M
Debt$17.46M
Short InterestN/A
Institutional Holdings
QoQ: ↓ 29.9% shares (2026Q1 vs prior)
17 institutional holders · 484.6K shares
#1
BlackRock, Inc.
258.8K shares
#2
GEODE CAPITAL MANAGEMENT, LLC
64.2K shares
#3
UBS Group AG
37.4K shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest179.8K
Days to Cover3.0
% of Float0.7%
FINRA data as of Jul 31, 2026
Recent SEC Activity
No recent SEC insights
Recent News
No recent news
Track MENS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking MENS — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for MENS
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.